Towards Personalization in the Curative Treatment of Gastric Cancer
Gastric cancer is the fifth most common cancer worldwide and has a high mortality rate. In the last decades, treatment strategy has shifted from an exclusive surgical approach to a multidisciplinary strategy. Treatment options for patients with resectable gastric cancer as recommended by different w...
Saved in:
Published in | Frontiers in oncology Vol. 10; p. 614907 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
30.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Gastric cancer is the fifth most common cancer worldwide and has a high mortality rate. In the last decades, treatment strategy has shifted from an exclusive surgical approach to a multidisciplinary strategy. Treatment options for patients with resectable gastric cancer as recommended by different worldwide guidelines, include perioperative chemotherapy, pre- or postoperative chemoradiotherapy and postoperative chemotherapy. Although gastric cancer is a heterogeneous disease with respect to patient-, tumor-, and molecular characteristics, the current standard of care is still according to a one-size-fits-all approach. In this review, we discuss the background of the different treatment strategies in resectable gastric cancer including the current standard, the specific role of radiotherapy, and describe the current areas of research and potential strategies for personalization of therapy. |
---|---|
Bibliography: | This article was submitted to Radiation Oncology, a section of the journal Frontiers in Oncology Reviewed by: Yee Ung, Sunnybrook Health Sciences Centre, Canada; Berardino De Bari, Hôpital Neuchâtelois, Switzerland Edited by: Francesco Cellini, Catholic University of the Sacred Heart, Italy |
ISSN: | 2234-943X 2234-943X |
DOI: | 10.3389/fonc.2020.614907 |